LNSR (LENSAR, Inc.) Stock Financials & Earnings | Market Cap Arena

LNSR (LENSAR, Inc.) Stock Financials & Earnings | Market Cap Arena

LNSRLENSAR, Inc.

Mkt Cap$142M

Healthcare·Medical - Devices·🇺🇸 United States·NASDAQ

Revenue (TTM)$59M

Net Income (TTM)-$52M

EPS (TTM)-$4.39

Free Cash Flow (TTM)-$12M

Gross Margin45.8%

Op. Margin-35.4%

Net Margin-87.1%

FCF Margin-20.1%

P/S Ratio (TTM)2.4x

P/E Ratio (TTM)—

YoY Rev Growth+21.0%

Employees—

Earnings Reports

Next: Q4 2025 · Mar 12

Revenue & Profitability

Quarter	Revenue	Gross Profit	Op. Income
Q4 22	$10M	$6M	-$3M
Q1 23	$8M	$4M	-$4M
Q2 23	$12M	$7M	-$3M
Q3 23	$10M	$5M	-$2M
Q4 23	$12M	$5M	-$3M
Q1 24	$11M	$5M	-$3M
Q2 24	$13M	$7M	-$2M
Q3 24	$14M	$6M	-$1M
Q4 24	$17M	$7M	-$1M
Q1 25	$14M	$7M	-$6M
Q2 25	$14M	$7M	-$6M
Q3 25	$14M	$6M	-$8M

Valuation

Quarter	P/S	P/E
Q4 22	4.0x	—
Q1 23	4.1x	—
Q2 23	3.7x	—
Q3 23	3.5x	—
Q4 23	3.4x	—
Q1 24	3.2x	—
Q2 24	3.1x	—
Q3 24	2.9x	—
Q4 24	2.7x	—
Q1 25	2.5x	—
Q2 25	2.4x	—
Q3 25	2.4x	—

Operating Cash Flow

Quarter	Operating CF	Free CF
Q4 22	-$5M	-$5M
Q1 23	-$7M	-$7M
Q2 23	-$2M	-$2M
Q3 23	-$339K	-$341K
Q4 23	-$480K	-$525K
Q1 24	-$5M	-$5M
Q2 24	-$4M	-$4M
Q3 24	$3M	$3M
Q4 24	$4M	$4M
Q1 25	-$7M	-$7M
Q2 25	-$5M	-$5M
Q3 25	-$4M	-$4M

Capital Expenditures

CapEx

Quarter	CapEx
Q4 22	$57K
Q1 23	$8K
Q2 23	$181K
Q3 23	$2K
Q4 23	$45K
Q1 24	$20K
Q2 24	$113K
Q3 24	$20K
Q4 24	$3K
Q1 25	$6K
Q2 25	$77K
Q3 25	$0

OpEx vs Revenue Growth (YoY)

Quarter	Revenue Growth	OpEx Growth
Q4 22	-8.8%	-15.1%
Q1 23	-11.6%	-21.3%
Q2 23	+49.4%	+0.3%
Q3 23	+26.4%	+0.0%
Q4 23	+18.3%	+17.3%
Q1 24	+28.3%	+6.5%
Q2 24	+5.2%	-4.7%
Q3 24	+38.2%	+23.0%
Q4 24	+38.2%	+19.6%
Q1 25	+33.7%	+48.5%
Q2 25	+10.3%	+42.6%
Q3 25	+5.7%	+50.5%

Stock-Based Compensation

Quarter	SBC ($)	% of Revenue
Q4 22	$2M	16.6%
Q1 23	$2M	20.9%
Q2 23	$2M	15.2%
Q3 23	$1M	12.0%
Q4 23	$816K	6.7%
Q1 24	$652K	6.2%
Q2 24	$683K	5.4%
Q3 24	$668K	4.9%
Q4 24	$662K	4.0%
Q1 25	$654K	4.6%
Q2 25	$766K	5.5%
Q3 25	$850K	5.9%

OpEx Breakdown

Quarter	R&D	SG&A
Q4 22	$2M	$7M
Q1 23	$2M	$7M
Q2 23	$1M	$8M
Q3 23	$2M	$5M
Q4 23	$1M	$6M
Q1 24	$1M	$7M
Q2 24	$1M	$7M
Q3 24	$1M	$6M
Q4 24	$1M	$7M
Q1 25	$2M	$11M
Q2 25	$1M	$12M
Q3 25	$1M	$12M

War Chest

Quarter	Cash	Short-term Investments	Total
Q4 22	$15M	$0	$15M
Q1 23	$8M	$0	$8M
Q2 23	$25M	$0	$25M
Q3 23	$25M	$0	$25M
Q4 23	$21M	$3M	$24M
Q1 24	$14M	$4M	$18M
Q2 24	$8M	$6M	$14M
Q3 24	$10M	$8M	$18M
Q4 24	$16M	$6M	$22M
Q1 25	$20M	$6M	$25M
Q2 25	$7M	$13M	$20M
Q3 25	$8M	$9M	$17M

Shares Outstanding

Shares Outstanding

Quarter	Shares (Diluted)	QoQ Change
Q4 22	10M	+1.4%
Q1 23	11M	+3.4%
Q2 23	11M	+1.0%
Q3 23	12M	+10.5%
Q4 23	11M	-6.0%
Q1 24	11M	+1.3%
Q2 24	11M	+0.6%
Q3 24	12M	+1.3%
Q4 24	12M	+0.2%
Q1 25	12M	+1.3%
Q2 25	12M	+1.4%
Q3 25	12M	+0.9%

Revenue Per Employee

Revenue / Employee

Year	Revenue/Employee	Employees
FY 18	—	—
FY 19	—	—
FY 20	$264K	100
FY 21	$313K	110
FY 22	$321K	110
FY 23	$324K	130
FY 24	$382K	140